JPH084453B2 - Mutagenic substance removal method - Google Patents
Mutagenic substance removal methodInfo
- Publication number
- JPH084453B2 JPH084453B2 JP62060298A JP6029887A JPH084453B2 JP H084453 B2 JPH084453 B2 JP H084453B2 JP 62060298 A JP62060298 A JP 62060298A JP 6029887 A JP6029887 A JP 6029887A JP H084453 B2 JPH084453 B2 JP H084453B2
- Authority
- JP
- Japan
- Prior art keywords
- peroxide
- milk
- enzyme
- peroxidase
- removal method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims description 7
- 239000003471 mutagenic agent Substances 0.000 title claims 4
- 235000013365 dairy product Nutrition 0.000 claims description 19
- 102000003992 Peroxidases Human genes 0.000 claims description 14
- 235000013336 milk Nutrition 0.000 claims description 13
- 210000004080 milk Anatomy 0.000 claims description 13
- 239000008267 milk Substances 0.000 claims description 13
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 13
- 230000003505 mutagenic effect Effects 0.000 claims description 4
- 235000013618 yogurt Nutrition 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 231100000707 mutagenic chemical Toxicity 0.000 claims 2
- 150000002978 peroxides Chemical class 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 17
- 108090000790 Enzymes Proteins 0.000 description 17
- 229940088598 enzyme Drugs 0.000 description 17
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 108010023244 Lactoperoxidase Proteins 0.000 description 4
- 102000045576 Lactoperoxidases Human genes 0.000 description 4
- 229940057428 lactoperoxidase Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 240000003291 Armoracia rusticana Species 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 3
- 108010053835 Catalase Proteins 0.000 description 3
- 102000016938 Catalase Human genes 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 231100000299 mutagenicity Toxicity 0.000 description 2
- 230000007886 mutagenicity Effects 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 102000010750 Metalloproteins Human genes 0.000 description 1
- 108010063312 Metalloproteins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 235000005733 Raphanus sativus var niger Nutrition 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 102100039094 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 108010093894 Xanthine oxidase Proteins 0.000 description 1
- 102100033220 Xanthine oxidase Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000001443 photoexcitation Effects 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000020185 raw untreated milk Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Dairy Products (AREA)
Description
【発明の詳細な説明】 産業上の利用分野 本発明は、乳製品中の変異原性物質の除去法に関す
る。更に詳細には、乳製品中の過酸化物に酵素を作用せ
しめて変異原性を除去する方法に関する。FIELD OF THE INVENTION The present invention relates to a method for removing mutagenic substances in dairy products. More specifically, it relates to a method for removing mutagenicity by causing an enzyme to act on a peroxide in a dairy product.
従来技術 近年、飲食品中に含まれる発ガン物質の1つとしての
過酸化物が注目されており、過酸化物が或る限度以上の
量食品中に存在すると発ガン誘起作用を示すことが報告
されている〔(Ito A.et al、Gann、72巻、174頁(1981
年)〕。かかる観点から、日常摂取する食品中の過酸化
物除去は非常に重大な課題であることが示唆される。BACKGROUND ART In recent years, attention has been paid to a peroxide as one of carcinogenic substances contained in foods and drinks, and when a peroxide is present in food in a certain amount or more, a carcinogenic effect may be exhibited. Reported [(Ito A. et al, Gann, 72, 174 (1981
Year)〕. From such a viewpoint, it is suggested that the removal of peroxides in foods that are ingested daily is a very important issue.
飲食品中の変異原性物質を酵素により消去した試みと
しては、コーヒーにペルオキシダーゼを作用せしめたも
の(特開昭60−62945)、コーヒーにカタラーゼを作用
せしめたもの(特開昭59−232049)、ビタミンC製剤に
カタラーゼを作用せしめたもの(特開昭60−54317)、
コーヒーにチロシナーゼを作用せしめたもの(特開昭60
−256348)などがある。As an attempt to eliminate mutagenic substances in foods and drinks with an enzyme, coffee was allowed to act with peroxidase (JP-A-60-62945), and coffee was allowed to act with catalase (JP-A-59-232049). , A vitamin C preparation with catalase acting (JP-A-60-54317),
Coffee with tyrosinase acting (JP-A-60
-256348) and so on.
このように一般に広く知られた突然変異原性を有する
食品に対して酵素処理をする報告は見られるものの、乳
製品に関しては全く報告されていない。As described above, although there are reports that enzyme treatment is performed on foods having mutagenicity, which is generally widely known, no report has been made on dairy products.
乳製品は、牛乳が主原料として用いられている。牛乳
は生牛乳を超高温殺菌(120〜150度、1〜3秒間)又は
高温短時間殺菌(72〜75度以上、15秒〜15分間)する方
法が行われており、かような処理により本来生牛乳中に
含まれているペルオキシダーゼが殺菌処理により失活し
てしまうのでもしも乳製品中に過酸化物質が多量に存在
するならば問題となりうるのである。それ故に乳製品の
消費はますます増大しつつあるにもかかわらず、該製品
の安全性を問うた報告をみないのは、消費者が毎日摂取
することを考えれば誠に憂慮すべきことである。Milk is mainly used as a raw material for dairy products. Milk is sterilized by ultra-high temperature (120-150 degrees, 1-3 seconds) or high-temperature short-time sterilization (72-75 degrees or more, 15 seconds-15 minutes). Since the peroxidase originally contained in raw milk is inactivated by the sterilization treatment, it can be a problem if a large amount of peroxide is present in the dairy product. Therefore, despite the ever-increasing consumption of dairy products, the lack of reports that question the safety of the product is truly alarming considering the daily intake by consumers. .
発明が解決すべき問題点 本発明は、上記の実情に鑑み安全な乳製品を提供する
ためにそして食品に含まれる過酸化物に注目し、種々の
乳製品について過酸化物存在の有無について検討した。
その結果全く意外にも乳製品中には、数〜数十ppmの過
酸化物が存在しているとの知見を得た。使用した乳製品
としてはスキムミルク、粉ミルク、市乳、脱脂粉乳、ヨ
ーグルト等が挙げられる。これらに含まれる過酸化物の
量を測定した結果、第1表に示される。Problems to be Solved by the Invention In view of the above circumstances, the present invention focuses on peroxides contained in foods in order to provide safe dairy products, and examines the presence or absence of peroxides in various dairy products. did.
As a result, it was found that, surprisingly, dairy products contain peroxides of several to several tens of ppm. Examples of dairy products used include skim milk, powdered milk, city milk, skim milk powder, yogurt and the like. The results of measuring the amounts of peroxide contained in these are shown in Table 1.
生乳中には通常ラクトペルオキシダーゼが約0.1単位/
ml以上含有されていることが知られているが、乳製品の
殺菌処理中に該酵素が失活してしまい、過酸化物の除去
が困難となると推考される。 Lactoperoxidase is normally present in milk in about 0.1 units /
It is known that the enzyme is contained in an amount of at least ml, but it is considered that the enzyme is deactivated during the sterilization treatment of dairy products, which makes it difficult to remove the peroxide.
問題点を解決すべき手段 前記の過酸化物としては、過酸化水素と過酸化脂質が
挙げられる。過酸化水素の場合は、主に酸素あるいは電
子供与体から、過酸化物質の場合は、主に不飽和脂肪酸
と酵素がそれぞれ前駆物質(基質)として関与する。Means for Solving the Problems Examples of the peroxide include hydrogen peroxide and lipid peroxide. In the case of hydrogen peroxide, oxygen or an electron donor is mainly involved, and in the case of a peroxide, unsaturated fatty acid and enzyme are mainly involved as precursors (substrates).
過酸化物生成に関わるものとしては、反応基質の他
に、電子を供与したり、引き抜いたりする物質やそれら
の反応を触媒する物質例えば、ピロガロールやアスコル
ビン酸等の還元剤、キサンチン酸化酵素,アルデヒド酸
化酵素等の酸化酵素、オキシヘモグロビンなどの酸素化
金属蛋白質、フエレドキシン,フラボドキシン等の自動
酸化、フラビン,プロトポルフイリンの光励起生成物、
X線照射、紫外線照射、O3、金属などがある。こうして
生成した過酸化物が動脈硬化、肝疾患、炎症、発癌など
の様々な疾病や老化の原因となることは周知の事実であ
る。従って、食品中から過酸化物を分解、除去する手段
としては、過酸化物生成系をブロツクするか、生成した
過酸化物を分解するかの2つの手段に大別される。前者
としては、いわゆる“抗酸化剤”がこれに属し、L−ア
スコルビン酸、グルタチオン(還元型)、尿酸、ビタミ
ンE、β−カロチン、ブチルヒドロキシアニソール、ブ
チルヒドロキシトルエン、プロピルガレート、没食子酸
などが挙げられる。又、後者には、亜硫酸のような還元
剤と過酸化物を分解する酵素が含まれる。酵素として
は、カタラーゼと各種のペルオキシダーゼ、フオスフオ
リパーゼやグルタチオントランスフエラーゼ等が知られ
ている。一般に飲食品中の過酸化物の分解除去を目的と
する場合、使用する基剤としては、下記の条件を満たす
ものでなくてはならない。In addition to reaction substrates, substances that donate or withdraw electrons or substances that catalyze their reactions, such as reducing agents such as pyrogallol and ascorbic acid, xanthine oxidases, and aldehydes are involved in peroxide generation. Oxidases such as oxidases, oxygenated metalloproteins such as oxyhemoglobin, autoxidation of pheledoxins and flavodoxins, photoexcitation products of flavins and protoporphyrins,
X-ray irradiation, ultraviolet irradiation, O 3 , metal, etc. It is a well known fact that the peroxide thus generated causes various diseases such as arteriosclerosis, liver disease, inflammation and carcinogenesis and aging. Therefore, the means for decomposing and removing the peroxide from the food is roughly classified into two means: blocking the peroxide generation system or decomposing the generated peroxide. As the former, so-called "antioxidants" belong to this, and L-ascorbic acid, glutathione (reduced form), uric acid, vitamin E, β-carotene, butylhydroxyanisole, butylhydroxytoluene, propylgallate, gallic acid, etc. Can be mentioned. The latter also includes reducing agents such as sulfite and enzymes that decompose peroxides. As enzymes, catalase, various peroxidases, phosphiolipase, glutathione transferase, etc. are known. Generally, for the purpose of decomposing and removing peroxides in foods and drinks, the base used must satisfy the following conditions.
(1)製品の官能的特性に悪影響を及ぼさないこと。(1) It does not adversely affect the sensory characteristics of the product.
(2)基剤自体、及び反応生成物が安全であること。(2) The base material itself and the reaction product are safe.
(3)褐変化等、品質面の劣化を促進しないこと。(3) Do not promote deterioration in quality such as browning.
(4)使用量はできる限り微量であること。(4) The amount used should be as small as possible.
これらの条件を満たす基剤としては、酵素が最も適し
ていると見られる。Enzymes seem to be the most suitable as the base material satisfying these conditions.
そこで本発明者らは、乳製品中に存在している過酸化
物を分解除去するために酵素、特にペルオキシダーゼを
用いることを検討した。Therefore, the present inventors examined the use of an enzyme, particularly peroxidase, for decomposing and removing the peroxide present in the dairy product.
ペルオキシダーゼは電子供与体+過酸化物→酸化型電
子供与体+2H2Oの反応を触媒する酵素であり、過酸化物
は速やかに除去される。ペルオキシダーゼは西洋ワサ
ビ,ダイコン,カブ等植物由来、牛乳,白血球等動物由
来、さらには微生物由来のものであってもよく、その純
度は問わない。使用する酵素の量としては、、通常0.1
〜1単位/mlの濃度で室温にて一定時間放置することに
より、天然に近い乳製品が得られるのである。反応温
度、反応時間は適宜調節することもでき、それに従い酵
素量は任意に選べることは酵素化学上論を待たない。Peroxidase is an enzyme that catalyzes the reaction of electron donor + peroxide → oxidized electron donor + 2H 2 O, and peroxide is rapidly removed. The peroxidase may be derived from plants such as horseradish, Japanese radish and turnip, derived from animals such as milk and white blood cells, and derived from microorganisms, and the purity thereof is not limited. The amount of enzyme used is usually 0.1
A dairy product close to natural can be obtained by leaving it at a concentration of 1 unit / ml at room temperature for a certain period of time. The reaction temperature and reaction time can be adjusted as appropriate, and it is not necessary to wait for enzymatic chemistry to discuss the amount of enzyme to be selected accordingly.
次に本発明者らは市販牛乳にペルオキシダーゼを作用
させた場合の官能テストを試みた。Next, the present inventors tried a sensory test when peroxidase was allowed to act on commercially available milk.
試験例 市販牛乳にラクトパーオキシダーゼを0.2μ/mlの濃度
になる様に添加し、2日間冷蔵庫に保管後任意に10人の
パネラーを選び、味、臭い、外観等の食品上問題となる
官能テストを行った。Test Example Lactoperoxidase was added to commercially available milk to a concentration of 0.2 μ / ml, and stored in the refrigerator for 2 days, then 10 panelists were selected arbitrarily, and the taste, smell, appearance, etc. I did a test.
外観の変化及び臭いに関しては10人のパネラー全てが
対照(ラクトパーオキシダーゼ無添加)と比較し差が認
められないと判定した。味に関しては10人中8人が、対
照と比べて軽いと判定し、2人が差がないと判定した。Regarding the change in appearance and odor, all 10 panelists judged that there was no difference compared with the control (without addition of lactoperoxidase). Regarding the taste, 8 out of 10 judged that it was lighter than the control, and 2 judged that there was no difference.
このようにして酵素処理した乳製品中には過酸化物が
全く存在しないので、安全な製品を提供することが可能
となった。In this way, since the dairy product treated with the enzyme does not contain any peroxide, it is possible to provide a safe product.
以下に本発明を実施例を挙げて詳細に説明するが、本
発明は何らこれらに限定されるものではない。Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.
「過酸化物の定量」 4−アミノアンチピリン8mg、TOOS(商品名)32mg及
びペルオキシダーゼ(西洋ワサビ由来)150単位を0.1N
−トリス塩酸緩衝液(pH7.0)100mlに溶解し反応液とし
た。この反応液2mlに試料1mlを添加し、室温で15分間放
置後コントロール(試料1mlの代わりに水を用いて同様
の操作をする)との比較、或いは555nmで測定し過酸化
物の陽性、陰性或いは過酸化水素を用いた検量線によ
り、過酸化水素量換算値を求めた。"Peroxide determination" 4-aminoantipyrine 8 mg, TOOS (trade name) 32 mg and peroxidase (derived from horseradish) 150 units 0.1 N
-Dissolved in 100 ml of Tris-HCl buffer (pH 7.0) to give a reaction solution. Add 1 ml of sample to 2 ml of this reaction solution, leave it at room temperature for 15 minutes, then compare with a control (use water instead of 1 ml for the same operation) or measure at 555 nm for positive and negative peroxides. Alternatively, a hydrogen peroxide conversion value was obtained from a calibration curve using hydrogen peroxide.
実施例1 過酸化物の存在するスキムミルク、市乳、ヨーグルト
にペルオキシダーゼを0.01〜0.5単位/mlの範囲で添加
し、室温で15分間放置後過酸化物の量を測定した。結果
を第2表に示す。Example 1 Peroxidase was added to skim milk, city milk, and yogurt in the presence of peroxide in the range of 0.01 to 0.5 unit / ml, and allowed to stand at room temperature for 15 minutes, and then the amount of peroxide was measured. The results are shown in Table 2.
第2表から判るように、室温、15分間放置で酵素量を
0.1単位/mlになるようにペルオキシダーゼを乳製品に添
加すれば過酸化物を除去することが可能である。 As can be seen from Table 2, the amount of enzyme was changed by leaving it at room temperature for 15 minutes.
Peroxides can be removed by adding peroxidase to dairy products at 0.1 unit / ml.
実施例2 市乳10mlにラクトペルオキシダーゼ(乳由来)、ペル
オキシダーゼ(ワサビ由来)及びペロオキシダーゼ(微
生物由来)を各々0.1単位/mlになるように添加し、25
度、15分間放置後、それぞれ1mlをとり過酸化物測定用
の反応液2mlに添加し、15分後にその発色を確認した。
その結果、酵素を添加しないものは発色が陽性であった
のに対し、酵素を添加したものは全て陰性であった。Example 2 Lactoperoxidase (derived from milk), peroxidase (derived from horseradish), and perooxidase (derived from microorganisms) were added to 10 ml of city milk at 0.1 unit / ml each, and 25
After standing for 15 minutes, 1 ml of each was taken and added to 2 ml of the reaction solution for peroxide measurement, and after 15 minutes, the color development was confirmed.
As a result, color development was positive in the case where the enzyme was not added, whereas it was negative in the case where the enzyme was added.
実施例3 市乳50mlを10,000rpmで20分間遠心分離を行った。そ
の中層液を2N酢酸を用いてpHを4.5に調整した後、10,00
0rpmで20分間遠心分離を行いその上澄液を2N水酸化ナト
リウム溶液でpHを7.0にし更に10,000rpmで20分間遠心分
離した。このようにして得られた酸ホエー液に実施例2
と同様の酵素処理を行い、過酸化物の測定を行った。第
3表から明らかなように、ペルオキシダーゼ処理により
過酸化物が完全に除去されていることが判る。Example 3 50 ml of city milk was centrifuged at 10,000 rpm for 20 minutes. After adjusting the pH of the middle layer solution to 4.5 with 2N acetic acid, 10,00
After centrifugation at 0 rpm for 20 minutes, the supernatant was adjusted to pH 7.0 with 2N sodium hydroxide solution and further centrifuged at 10,000 rpm for 20 minutes. Example 2 was added to the acid whey solution thus obtained.
The same enzymatic treatment as in (2) above was carried out to measure the peroxide. As is apparent from Table 3, the peroxide was completely removed by the peroxidase treatment.
発明の効果 本発明のペルオキシダーゼを用いた乳製品中の過酸化
物の除去方法は、安全且つ確実な方法であって、優れた
乳製品を提供しうるのである。 EFFECTS OF THE INVENTION The method for removing peroxide in a dairy product using the peroxidase of the present invention is a safe and reliable method and can provide an excellent dairy product.
───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭60−62945(JP,A) ─────────────────────────────────────────────────── --Continued from the front page (56) References JP-A-60-62945 (JP, A)
Claims (2)
ゼを作用させることを特徴とする変異原性物質の除去
法。1. A method for removing a mutagen, which comprises allowing a peroxidase to act on a mutagen in a dairy product.
群より選ばれる特許請求の範囲第1項記載の変異原性物
質の除去法。2. The method for removing a mutagenic substance according to claim 1, wherein the dairy product is selected from the group consisting of milk, milk powder and yogurt.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62060298A JPH084453B2 (en) | 1987-03-16 | 1987-03-16 | Mutagenic substance removal method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62060298A JPH084453B2 (en) | 1987-03-16 | 1987-03-16 | Mutagenic substance removal method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63226243A JPS63226243A (en) | 1988-09-20 |
| JPH084453B2 true JPH084453B2 (en) | 1996-01-24 |
Family
ID=13138122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62060298A Expired - Lifetime JPH084453B2 (en) | 1987-03-16 | 1987-03-16 | Mutagenic substance removal method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH084453B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023008491A1 (en) | 2021-07-27 | 2023-02-02 | 合同酒精株式会社 | Enzyme-containing composition, method for producing milk and method for producing fermented milk |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69228845T2 (en) * | 1991-01-23 | 1999-10-07 | Snow Brand Milk Products Co., Ltd. | STARTER CULTURE CONTAINING PEROXIDASE OF A LACTIC ACID BACTERIUM, FERMENTED MILK PRODUCT AND ITS PRODUCTION |
| JP3145829B2 (en) * | 1993-03-26 | 2001-03-12 | 雪印乳業株式会社 | Fermented milk and method for producing the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6062945A (en) * | 1983-09-16 | 1985-04-11 | Suntory Ltd | Preparation of coffee drink free from mutagenecity |
-
1987
- 1987-03-16 JP JP62060298A patent/JPH084453B2/en not_active Expired - Lifetime
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023008491A1 (en) | 2021-07-27 | 2023-02-02 | 合同酒精株式会社 | Enzyme-containing composition, method for producing milk and method for producing fermented milk |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63226243A (en) | 1988-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chow et al. | Vitamin E regulates mitochondrial hydrogen peroxide generation | |
| Strain | Newer aspects of micronutrients in chronic disease: copper | |
| Davis | Low dietary copper increases fecal free radical production, fecal water alkaline phosphatase activity and cytotoxicity in healthy men | |
| Ouchi et al. | Kinetic study of the antioxidant activity of pyrroloquinolinequinol (PQQH2, a reduced form of pyrroloquinolinequinone) in micellar solution | |
| Kulkarni et al. | Hydroperoxidase activity of lipoxygenase: hydrogen peroxide-dependent oxidation of xenobiotics | |
| Reddy et al. | Alterations in lipid peroxides in rat liver by dietary n-3 fatty acids: modulation of antioxidant enzymes by curcumin, eugenol, and vitamin E | |
| Nelson et al. | Copper-marginal and copper-deficient diets decrease aortic prostacyclin production and copper-dependent superoxide dismutase activity, and increase aortic lipid peroxidation in rats | |
| JP5637209B2 (en) | Aldehyde removal composition | |
| JP2021528961A (en) | Composition containing fish protein hydrolyzate powder and said powder for pharmaceutical use | |
| HARRIS et al. | Substrate specificity of mackerel flesh lipopolygenase | |
| Kahn | Multiple effects of hydrogen peroxide on the activity of avocado polyphenol oxidase | |
| JP2009029710A (en) | Antioxidant, anti-aging agent, anti-inflammatory agent, hair restorer, anti-obesity agent, endothelin-1 mRNA expression increase inhibitor, and cosmetic and beauty food and drink | |
| MARTINEZ‐CAYUELA et al. | Cherimoya (Annona cherimola Mill) polyphenoloxidase: Monophenolase and dihydroxyphenolase activities | |
| Roy et al. | Oxidation of ascorbic acid by lipoxygenase: effect of selected chemicals | |
| JPH084453B2 (en) | Mutagenic substance removal method | |
| Ames | Carcinogens and anticarcinogens | |
| Maduka et al. | The effect of Sacoglottis gabonensis stem bark extract, a Nigerian alcoholic beverage additive, on the natural antioxidant defences during 2, 4-dinitrophenyl hydrazine-induced membrane peroxidation in vivo | |
| Packer et al. | The antioxidant vitamins C and E | |
| Vasavi et al. | Effect of α-tocopherol on lipid peroxidation and antioxidant system in fibrosarcoma bearing rats | |
| Draper et al. | Role of nutrients in the cause and prevention of oxygen radical pathology | |
| Schwartz et al. | In-mouth metabolism of flavor compounds | |
| Powers et al. | The adventures of superoxide dismutase in health and disease: superoxide in the balance | |
| Horio et al. | A newly established strain of spontaneously hypertensive rat with a defect of ascorbic acid biosynthesis | |
| Barakat et al. | Studies of fatty acid oxidation in homogenates of the cardiomyopathic hamster | |
| Simonetti et al. | Effect of red wine consumption on rat liver peroxidation |